Danny Farin, BSc, MBA, Entrepreneur in the biomed industry.
Yehuda Bachar, MSc, R&D Engineer. Senior engineer with over 15 years in biomed, including Top Engineering, SteadyMed, Fergilant and EON.
Saturix developed the next generation solution for intracorporeal suturing, which dramatically simplifies and shortens the procedure, thus enhancing surgeon`s performance and increasing safety.
Suturing is one of the most complex, time consuming, risk related and difficult to acquire procedures, involved in laparoscopic surgeries. The surgeon relies on a 2- dimensional screen, trying to implement a 3- dimensional maneuver with a needle and a long thread inside the limited surgical field of the abdomen. This is an advanced skill with a very slow learning curve which requires a high level of psycho motor skills and competency from the surgeon.
Almost 1.5 Million laparoscopic surgeries requiring suturing are performed annually.
The relevant laparoscopic market is characterized by 8-20% annual growth.
Initial potential market of 550 M$ a year.
High reimbursement rate (17-30K$).
High acceptance of innovative product.
Growth enabler – more surgeons, performing more procedures using more laparoscopic systems and tools.
Saturix will focus initially on bariatric surgeries.